Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry
- PMID: 33074480
- DOI: 10.1007/s12185-020-03010-9
Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry
Abstract
Hereditary red blood cell (RBC) membranopathies are characterized by mutations in genes encoding skeletal proteins that alter the membrane complex structure. Hereditary spherocytosis (HS) is the most common inherited RBC membranopathy leading to hereditary hemolytic anemia with a worldwide distribution and an estimated prevalence, in Europe, of about 1:2000 individuals. The recent availability of targeted next generation sequencing (t-NGS) and its combination with RBC deformability measured with a laser-assisted optical rotational ektacytometer (LoRRca) has demonstrated to be the most powerful contribution to lower the percentage of hereditary hemolytic anemia undiagnosed cases. In order to know the kind and frequency of RBC membrane mutations in our geographical area (Catalonia) and to better understand their pathophysiology, 42 unrelated, non-transfusion-dependent (NTD) patients with hereditary hemolytic anemia have been studied by combining t-NGS and LoRRca. The osmoscan module of LoRRca provides three rheological profiles that reflect the maximal deformability (EImax), osmotic fragility (Omin), and hydration state (Ohyper) of RBCs and contribute to a better understanding of the contribution RBC rheology to the severity of anemia. From the 42 patients studied, 37 were suspected to be a RBC membrane defect due to phenotypic characteristics and abnormal RBC morphology and, from these, in 31 patients (83.8% of cases) the mutation was identified by t-NGS. No definite diagnosis was achieved in 11 patients (26.2% of cases), including 6 out of 37 cases, with suspected membranopathy, and 5 with unclassifiable HHA. In all these undiagnosed patients, the existence of hemoglobinopathy and/or enzymopathy was ruled out by conventional methods.
References
-
- Vives Corrons JL. The Rare Anaemias. DOI:http//dx.doi.org/105772/intechopen.86986. 20191.
-
- Iolascon A, Andolfo I, Russo R. Advances in understanding the pathogenesis of red cell membrane disorders Brit. J Haematol. 2019;187:13–24. - DOI
-
- Zarza R, Moscardó M, Alvarez R, Morey M, Pujades A. Vives Corrons JL Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK Mallorca. Haematologica. 2000;85:227–32. - PubMed
-
- Fermo E, Vercellati C, Marcello AP, Zanioni A, van Wijk R, Mirra N, et al. Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families. Hindawi Case Rep Hematol. 2017;2017:2769570.
-
- Roy NB, Wilson EA, Henderson S, Wray K, Babbs C, Okoli S, et al. A novel 33-Gene-targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Brit J Haematol. 2016;175:318. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
